Manufacturer of Controlled Substances; Notice of Application; Correction, 53280-53281 [E8-21461]

Download as PDF 53280 Federal Register / Vol. 73, No. 179 / Monday, September 15, 2008 / Notices profit. Other: Not-for-Profit Institutions; State, Local or Tribal Government. Abstract: All firms and individuals who distribute or dispense controlled substances must register with the DEA under the Controlled Substances Act. Registration is needed for control measures over legal handlers of controlled substances and is used to monitor their activities. (5) An estimate of the total number of respondents and the amount of time estimated for an average respondent to respond: It is estimated that 12,094 persons complete DEA Form 224 on paper, at 12 minutes per form, for an annual burden of 2,418.8 hours. It is estimated that 59,283 persons complete DEA Form 224 electronically, at 8 minutes per form, for an annual burden of 7,904.4 hours. It is estimated that 159,678 persons complete DEA Form 224a on paper, at 12 minutes per form, for an annual burden of 31,935.6 hours. It is estimated that 209,535 persons complete DEA Form 224a electronically, at 4 minutes per form, for an annual burden of 13,969 hours. It is estimated that 16 persons complete DEA Form 224b, at 5 hours per form, for an annual burden of 80 hours. (6) An estimate of the total public burden (in hours) associated with the collection: It is estimated that this collection will create a burden of 56,307.8 annual burden hours. If additional information is required contact: Lynn Bryant, Department Clearance Officer, United States Department of Justice, Justice Management Division, Policy and Planning Staff, Patrick Henry Building, Suite 1600, 601 D Street, NW., Washington, DC 20530. Dated: September 9, 2008. Lynn Bryant, Department Clearance Officer, PRA, U.S. Department of Justice. [FR Doc. E8–21442 Filed 9–12–08; 8:45 am] BILLING CODE 4410–09–P DEPARTMENT OF JUSTICE Drug Enforcement Administration Overview Information Collection 1117– 0015 mstockstill on PROD1PC66 with NOTICES [OMB Number 1117–0015] Agency Information Collection Activities: Proposed Collection; Comments Requested: Application for Registration (DEA Form 363) and Application for Registration Renewal (DEA Form 363a) 60-Day Notice of Information Collection Under Review. ACTION: The Department of Justice (DOJ), Drug Enforcement Administration (DEA), will VerDate Aug<31>2005 20:22 Sep 12, 2008 Jkt 214001 be submitting the following information collection request to the Office of Management and Budget (OMB) for review and approval in accordance with the Paperwork Reduction Act of 1995. The proposed information collection is published to obtain comments from the public and affected agencies. Comments are encouraged and will be accepted until November 14, 2008. This process is conducted in accordance with 5 CFR 1320.10. If you have comments, especially on the estimated public burden or associated response time, suggestions, or need a copy of the proposed information collection instrument with instructions or additional information, please contact Mark W. Caverly, Chief, Liaison and Policy Section, Office of Diversion Control, Drug Enforcement Administration, 8701 Morrissette Drive, Springfield, VA 22152, Telephone (202) 307–7297. Written comments and suggestions from the public and affected agencies concerning the proposed collection of information are encouraged. Your comments should address one or more of the following four points: • Evaluate whether the proposed collection of information is necessary for the proper performance of the functions of the agency, including whether the information will have practical utility; • Evaluate the accuracy of the agencies estimate of the burden of the proposed collection of information, including the validity of the methodology and assumptions used; • Enhance the quality, utility, and clarity of the information to be collected; and • Minimize the burden of the collection of information on those who are to respond, including through the use of appropriate automated, electronic, mechanical, or other technological collection techniques or other forms of information technology, e.g., permitting electronic submission of responses. (1) Type of Information Collection: Extension of a currently approved collection. (2) Title of the Form/Collection: Application for Registration (DEA Form 363) and Application for Registration Renewal (DEA Form 363a). (3) Agency form number, if any, and the applicable component of the Department of Justice sponsoring the collection: Form Number: DEA Form 363 and 363a; Office of Diversion PO 00000 Frm 00093 Fmt 4703 Sfmt 4703 Control, Drug Enforcement Administration, Department of Justice. (4) Affected public who will be asked or required to respond, as well as a brief abstract: Primary: Business or other forprofit. Other: Not-for-profit institutions; State, Local, or Tribal Government. Abstract: Practitioners who dispense narcotic drugs to individuals for maintenance or detoxification treatment must register with the DEA under the Narcotic Addiction Treatment Act of 1974. Registration is needed for control measures and is used to prevent diversion. (5) An estimate of the total number of respondents and the amount of time estimated for an average respondent to respond: It is estimated that 33 persons complete DEA Form 363 on paper, at 30 minutes per form, for an annual burden of 16.5 hours. It is estimated that 96 persons complete DEA Form 363 electronically, at 8 minutes per form, for an annual burden of 12.8 hours. It is estimated that 614 persons complete DEA Form 363a on paper, at 30 minutes per form, for an annual burden of 307 hours. It is estimated that 537 persons complete DEA Form 363a electronically, at 8 minutes per form, for an annual burden of 71.6 hours. (6) An estimate of the total public burden (in hours) associated with the collection: It is estimated that this collection will create a burden of 407.9 annual burden hours. If additional information is required contact: Lynn Bryant, Department Clearance Officer, United States Department of Justice, Justice Management Division, Policy and Planning Staff, Patrick Henry Building, Suite 1600, 601 D Street, NW., Washington, DC 20530. Dated: September 9, 2008. Lynn Bryant, Department Clearance Officer, PRA, U.S. Department of Justice. [FR Doc. E8–21443 Filed 9–12–08; 8:45 am] BILLING CODE 4410–09–P DEPARTMENT OF JUSTICE Drug Enforcement Administration Manufacturer of Controlled Substances; Notice of Application; Correction On August 6, 2008, the Drug Enforcement Administration (DEA) published a Notice of Application for Registration for Chattem Chemicals Inc., 3801 St. Elmo Avenue, Building 18, Chattanooga, Tennessee 37409 in the Federal Register pursuant to 21 CFR 1301.33(a) (73 FR 45784). On May 28, E:\FR\FM\15SEN1.SGM 15SEN1 Federal Register / Vol. 73, No. 179 / Monday, September 15, 2008 / Notices 2008, Chattem Chemicals Inc., had made application by renewal to DEA as a bulk manufacturer of the certain basic classes of controlled substances listed in schedules I and II. The Notice of Application published August 6, 2008, listed the following basic classes of controlled substances for which Chattem Chemicals Inc. sought registration as a bulk manufacturer: Drug Drug I I II II II II II II II II II Executive Office for Immigration Review [OMB Number 1125–0002] Agency Information Collection Activities: Proposed Collection; Comments Requested 60-Day Notice of Information Collection Under Review: Notice of Appeal from a Decision of an Immigration Judge. ACTION: II II II II II II Schedule Lisdexamfetamine Mesylate (1205). Dihydrocodeine (9120) ................. Dihydromorphine (9145) ............... Hydromorphone (9150) ................ Oripavine (9330) ........................... Oxymorphone (9652) ................... Reminfentanil (9739) .................... mstockstill on PROD1PC66 with NOTICES BILLING CODE 4410–09–P DEPARTMENT OF JUSTICE DEA inadvertently did not include the following substances for which Chattem Chemicals Inc. also seeks registration as a bulk manufacturer: II II II II II II II The company plans to manufacture the listed controlled substances in bulk for distribution to its customers. Any other such applicant, and any person who is presently registered with DEA to manufacture such substances, may file comments or objections to the issuance of the proposed registration pursuant to 21 CFR 1301.33(a). Any such written comments or objections should be addressed, in quintuplicate, to the Drug Enforcement Administration, Federal Register Representative (ODL), 8701 Morrissette Drive, Springfield, Virginia 22152. As DEA inadvertently did not include all basic classes of controlled substances for which Chattem Chemicals Inc. sought registration in the Notice of Application published August 6, 2008, DEA is extending the comment period for this application in accordance with 21 CFR 1301.33(a). Therefore, the comment period for this application is 20:22 Sep 12, 2008 Dated: September 8, 2008. Joseph T. Rannazzisi, Deputy Assistant Administrator, Office of Diversion Control, Drug Enforcement Administration. [FR Doc. E8–21461 Filed 9–12–08; 8:45 am] Schedule 4-Methoxyamphetamine (7411) ... Difenoxin (9168) ........................... Amphetamine (1100) .................... Methamphetamine (1105) ............ Methylphenidate (1724) ................ Pentobarbital (2270) ..................... Codeine (9050) ............................. Oxycodone (9143) ........................ Hydrocodone (9193) ..................... Meperidine (9230) ........................ Dextropropoxyphene, bulk (nondosage forms) (9273). Morphine (9300) ........................... Thebaine (9333) ........................... Noroxymorphone (9668) .............. Alfentanil (9737) ........................... Sufentanil (9740) .......................... Fentanyl (9801) ............................ VerDate Aug<31>2005 extended from October 6, 2008 to November 14, 2008. Jkt 214001 The Department of Justice (DOJ), Executive Office for Immigration Review (EOIR) will be submitting the following information collection request to the Office of Management and Budget (OMB) for review and approval in accordance with the Paperwork Reduction Act of 1995. The proposed information collection is published to obtain comments from the public and affected agencies. Comments are encouraged and will be accepted for ‘‘sixty days’’ until November 14, 2008. This process is conducted in accordance with 5 CFR 1320.10. If you have comments especially on the estimated public burden or associated response time, suggestions, or need a copy of the proposed information collection instrument with instructions or additional information, please contact John N. Blum, Acting General Counsel, Executive Office for Immigration Review, U.S. Department of Justice, Suite 2600, 5107 Leesburg Pike, Falls Church, Virginia, 22041; telephone: (703) 305–0470. Written comments and suggestions from the public and affected agencies concerning the proposed collection of information are encouraged. Your comments should address one or more of the following four points: —Evaluate whether the collection of information is necessary for the proper performance of the functions of the agency, including whether the information will have practical utility; —Evaluate the accuracy of the agency’s estimate of the burden of the proposed collection of information, including the validity of the methodology and assumptions used; PO 00000 Frm 00094 Fmt 4703 Sfmt 4703 53281 —Enhance the quality, utility, and clarity of the information to be collected; and —Minimize the burden of the collection of information on those who are to respond, including through the use of appropriate automated, electronic, mechanical, or other technological collection techniques or other forms of information technology, e.g., permitting electronic submission of responses. Overview of This Information Collection (1) Type of Information Collection: Revision of a currently approved collection. (2) Title of the Form/Collection: Notice of Appeal from a Decision of an Immigration Judge. (3) Agency form number, if any, and the applicable component of the Department of Justice sponsoring the collection: Form EOIR–26, Executive Office for Immigration Review, United States Department of Justice. (4) Affected public who will be asked or required to respond, as well as a brief abstract: Primary: A party (either the U.S. Immigration and Customs Enforcement of the Department of Homeland Security or the respondent/ applicant) who appeals a decision of an Immigration Judge to the Board of Immigration Appeals (Board). Other: None. Abstract: A party affected by a decision of an Immigration Judge may appeal that decision to the Board, provided that the Board has jurisdiction pursuant to 8 CFR 1003.1(b). An appeal from an Immigration Judge’s decision is taken by completing the Form EOIR–26 and submitting it to the Board. (5) An estimate of the total number of respondents and the amount of time estimated for an average respondent to respond: It is estimated that 23,417 respondents will complete the form annually with an average of thirty minutes per response. (6) An estimate of the total public burden (in hours) associated with the collection: There are an estimated 11,708.5 total burden hours associated with this collection annually. If additional information is required, contact: Lynn Bryant, Department Clearance Officer, United States Department of Justice, Justice Management Division, Policy and Planning Staff, Patrick Henry Building, Suite 1600, 601 D Street, NW., Washington, DC 20530. E:\FR\FM\15SEN1.SGM 15SEN1

Agencies

[Federal Register Volume 73, Number 179 (Monday, September 15, 2008)]
[Notices]
[Pages 53280-53281]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E8-21461]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration


Manufacturer of Controlled Substances; Notice of Application; 
Correction

    On August 6, 2008, the Drug Enforcement Administration (DEA) 
published a Notice of Application for Registration for Chattem 
Chemicals Inc., 3801 St. Elmo Avenue, Building 18, Chattanooga, 
Tennessee 37409 in the Federal Register pursuant to 21 CFR 1301.33(a) 
(73 FR 45784). On May 28,

[[Page 53281]]

2008, Chattem Chemicals Inc., had made application by renewal to DEA as 
a bulk manufacturer of the certain basic classes of controlled 
substances listed in schedules I and II. The Notice of Application 
published August 6, 2008, listed the following basic classes of 
controlled substances for which Chattem Chemicals Inc. sought 
registration as a bulk manufacturer:

------------------------------------------------------------------------
                    Drug                               Schedule
------------------------------------------------------------------------
 4-Methoxyamphetamine (7411)...............   I
 Difenoxin (9168)..........................   I
 Amphetamine (1100)........................   II
 Methamphetamine (1105)....................   II
 Methylphenidate (1724)....................   II
 Pentobarbital (2270)......................   II
 Codeine (9050)............................   II
 Oxycodone (9143)..........................   II
 Hydrocodone (9193)........................   II
 Meperidine (9230).........................   II
 Dextropropoxyphene, bulk (non-dosage         II
 forms) (9273).
 Morphine (9300)...........................   II
 Thebaine (9333)...........................   II
 Noroxymorphone (9668).....................   II
 Alfentanil (9737).........................   II
 Sufentanil (9740).........................   II
 Fentanyl (9801)...........................   II
------------------------------------------------------------------------

    DEA inadvertently did not include the following substances for 
which Chattem Chemicals Inc. also seeks registration as a bulk 
manufacturer:

------------------------------------------------------------------------
                    Drug                               Schedule
------------------------------------------------------------------------
 Lisdexamfetamine Mesylate (1205)..........   II
 Dihydrocodeine (9120).....................   II
 Dihydromorphine (9145)....................   II
 Hydromorphone (9150)......................   II
 Oripavine (9330)..........................   II
 Oxymorphone (9652)........................   II
 Reminfentanil (9739)......................   II
------------------------------------------------------------------------

    The company plans to manufacture the listed controlled substances 
in bulk for distribution to its customers.
    Any other such applicant, and any person who is presently 
registered with DEA to manufacture such substances, may file comments 
or objections to the issuance of the proposed registration pursuant to 
21 CFR 1301.33(a).
    Any such written comments or objections should be addressed, in 
quintuplicate, to the Drug Enforcement Administration, Federal Register 
Representative (ODL), 8701 Morrissette Drive, Springfield, Virginia 
22152.
    As DEA inadvertently did not include all basic classes of 
controlled substances for which Chattem Chemicals Inc. sought 
registration in the Notice of Application published August 6, 2008, DEA 
is extending the comment period for this application in accordance with 
21 CFR 1301.33(a). Therefore, the comment period for this application 
is extended from October 6, 2008 to November 14, 2008.

    Dated: September 8, 2008.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of Diversion Control, Drug 
Enforcement Administration.
[FR Doc. E8-21461 Filed 9-12-08; 8:45 am]
BILLING CODE 4410-09-P

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.